Xencor's Series B Round

Xencor raised a round of funding on June 14, 1999. Investors include Stafford Investments.

Xencor engineers biotherapeutics using its Protein Design Automation technology platform, and is a provider in the field of antibody engineering to significantly improve antibody half-life, immune-reg…

Articles about Xencor's Series B Round: